OTCMKTS:PROT

Proteonomix Stock Forecast, Price & News

$0.0002
0.00 (0.00 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
▼
$0.00
50-Day Range
$0.00
▼
$0.02
52-Week Range
$0.00
▼
$0.03
VolumeN/A
Average Volume27,087 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive PROT News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteonomix and its competitors with MarketBeat's FREE daily newsletter.


About Proteonomix

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.

Headlines

PreVu, Inc. (PRVU)
PreVu, Inc. (PRVU)
June 17, 2021 |  finance.yahoo.com
Proteonomix, Inc. (OTCMKTS:PROT) Sees Significant Drop in Short Interest
Proteonomix, Inc. (OTCMKTS:PROT) Sees Significant Drop in Short Interest
May 28, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

0.48 out of 5 stars

Medical Sector

1687th out of 2,101 stocks

Biotechnology Industry

54th out of 89 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Proteonomix (OTCMKTS:PROT) Frequently Asked Questions

What stocks does MarketBeat like better than Proteonomix?

Wall Street analysts have given Proteonomix a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Proteonomix wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Proteonomix?

Proteonomix saw a decrease in short interest in May. As of May 14th, there was short interest totaling 500 shares, a decrease of 66.7% from the April 29th total of 1,500 shares. Based on an average trading volume of 1,200 shares, the days-to-cover ratio is currently 0.4 days.
View Proteonomix's Short Interest.

How has Proteonomix's stock price been impacted by Coronavirus?

Proteonomix's stock was trading at $0.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PROT stock has decreased by 98.0% and is now trading at $0.0002.
View which stocks have been most impacted by COVID-19.

Who are Proteonomix's key executives?

Proteonomix's management team includes the following people:
  • Mr. Michael Cohen, Founder, Chairman, CEO, Pres & COO (Age 54)
  • Mr. Steven Byle, CTO & Director (Age 53)
  • Mr. Jason B. Isaacs, Sec. (Age 49)
  • Ms. Jaci Mandil, Chief Exec. Officer of Proteoderm

Who are some of Proteonomix's key competitors?

Some companies that are related to Proteonomix include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX).
View all of PROT's competitors.

What is Proteonomix's stock symbol?

Proteonomix trades on the OTCMKTS under the ticker symbol "PROT."

How do I buy shares of Proteonomix?

Shares of PROT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Proteonomix's stock price today?

One share of PROT stock can currently be purchased for approximately $0.00.

What is Proteonomix's official website?

The official website for Proteonomix is stromacel.com.

Where are Proteonomix's headquarters?

Proteonomix is headquartered at 187 Mill Ln, MOUNTAINSIDE, NJ 07092-2918, United States.

How can I contact Proteonomix?

Proteonomix's mailing address is 187 Mill Ln, MOUNTAINSIDE, NJ 07092-2918, United States. The biotechnology company can be reached via phone at +1-973-5446116.


This page was last updated on 6/21/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.